February 19-23: Molecular Medicine Tri-Con 2012 will be held in San Francisco, with a section on fragments on February 21.
March 13-14: Select Biosciences is holding its Discovery Chemistry Congress in Munich, Germany, with a full two days devoted to fragment-based lead discovery.
March 19-23: Keystone Symposium: Addressing the Challenges of Drug Discovery – Novel Targets, New Chemical Space and Emerging Approaches will be held in Tahoe City, CA. Although not exclusively devoted to fragments, there are many speakers I look forward to hearing.
April 17-18: Cambridge Healthtech Institute’s Seventh Annual Fragment-Based Drug Discovery will be held in San Diego, with short courses on SPR and FBLD taking place on April 16. This is a chance to meet both editors of Practical Fragments! You can read impressions of last year’s meeting here and 2010’s here.
April 27: Dr. Teddy Z will be giving a webinar on NMR in hit-to-lead discovery.
May 13-17: The 30th Noordwijkerhout-Camerino-Cyprus Symposium Trends in Drug Research will be held in Amsterdam, including a session on fragment-based drug discovery.
June 6-8: Cambridge Healthtech Institute’s Twelth Annual Structure-Based Drug Design will be held in Boston, with a session on FBLD.
August 19-23: The Fall 2012 ACS meeting will take place in Philadelphia, PA, and has at least one section on fragment-based drug discovery.
September 23-26: Finally, FBLD 2012, the fourth in an illustrious series of conferences, will be held in my fair city of San Francisco. This should be a biggy – the first such event in the Bay Area (and the weather in September is usually decent too). You can read impressions of FBLD 2010 and FBLD 2009.
March 4-5: Fragments 2013, the 4th RSC-BMCS Fragment-based Drug Discovery meeting will be held at the Harwell Science and Innovation Campus near Oxford, UK.
Know of anything else? Organizing a fragment event? Let us know and we’ll get the word out.